sublingual tirzepatide clinical trial What Is Used for? Approved and Potential Uses Sublingual Tirzepatide for Weight Loss:

The most common symptoms are nausea, vomiting, diarrhea, constipation, bloating, abdominal discomfort, and reduced appetite

Evaluated transdermal delivery of copper tripeptide, demonstrating penetration through skin layers with potential for topical therapeutic applications

The SURPASS clinical trial program demonstrated that tirzepatide at its highest dose (15 mg weekly) produced average weight loss of 20-25% of body weight, significantly exceeding the results seen with GLP-1 only agonists

Visibly lightens the complexion, targeting deep-seated discoloration, stubborn spots, and brown patches on the face and neck